Patients with bulky NHL had significantly higher levels of bFGF (>10 pg ml−1) than patients with non-bulky disease (29.4% and 7.7% respectively, P=0.046); no correlation with either overall survival or PFS was found. This evidence concerns the gene FGF2 and non-Hodgkin lymphoma.